- £5.70bn
- £6.83bn
- £2.94bn
- 24
- 71
- 34
- 35
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,537 | 2,513 | 2,960 | 2,892 | 2,937 |
Cost of Revenue | |||||
Gross Profit | 2,052 | 2,060 | 2,403 | 2,361 | 2,334 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,943 | 1,966 | 2,284 | 2,382 | 2,500 |
Operating Profit | 594 | 546 | 676 | 509 | 437 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 625 | 611 | 764 | 587 | 488 |
Provision for Income Taxes | |||||
Net Income After Taxes | 496 | 486 | 624 | 486 | 403 |
Net Income Before Extraordinary Items | |||||
Net Income | 496 | 486 | 624 | 486 | 403 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 496 | 486 | 624 | 486 | 403 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.335 | 0.333 | 0.401 | 0.348 | 0.342 |
Dividends per Share |